Since these changes in serum and brain metabolome are associated with future conversion to AD, and brain hypometabolism is also an early event in AD, this raises an intriguing possibility that brain endothelial cells sense these changes and downregulate GLUT1 in response, thereby contributing to AD progression. Here, SLC2A1 is linked to Alzheimer disease.